Meadow Creek Investment Management’s West Pharmaceutical WST Stock Holding History

Meadow Creek Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.75M	Hold	12,348	–	–	0.03%	353
2019 Q2	$1.54M	Hold	12,348	–	–	0.03%	389
2019 Q1	$1.36M	Hold	12,348	–	–	0.03%	388
2018 Q4	$1.21M	Buy	12,348 +364	+3%	+$39.5K	0.03%	381
2018 Q3	$1.48M	Buy	11,984 +2,240	+23%	+$251K	0.03%	375
2018 Q2	$967K	Hold	9,744	–	–	0.02%	444
2018 Q1	$860K	Hold	9,744	–	–	0.02%	467
2017 Q4	$961K	Buy	9,744 +1,512	+18%	+$148K	0.02%	456
2017 Q3	$792K	Buy	8,232 +1,148	+16%	+$104K	0.02%	478
2017 Q2	$670K	Buy	7,084 +2,772	+64%	+$255K	0.02%	515
2017 Q1	$352K	Buy	4,312 +644	+18%	+$53.9K	0.01%	633
2016 Q4	$311K	Buy	+3,668	New	+$288K	0.01%	622

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Meadow Creek Investment Management's WST Position: Q3 2019 in Review

Meadow Creek Investment Management held its West Pharmaceutical (WST) position steady in Q3 2019 at 12,348 shares worth $1.75M. The position accounts for 0.03% of the portfolio, ranked #353.

Meadow Creek Investment Management first reported a position in WST in Q4 2016 and has held it in 12 quarters since. 406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

Meadow Creek Investment Management held 12,348 shares of West Pharmaceutical worth $1.75M as of Q3 2019.
Meadow Creek Investment Management left its West Pharmaceutical share count unchanged in Q3 2019.
West Pharmaceutical made up 0.03% of Meadow Creek Investment Management's portfolio in Q3 2019, its #353 holding.
Meadow Creek Investment Management first reported a position in West Pharmaceutical in Q4 2016 and has held it in 12 quarters since.
406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.